Gynecologic Cancer News

Amid the COVID-19 pandemic, people are putting off care, letting self-care strategies slip and falling back into unhealthy habits as they spend more time isolated and at home.

Today is International HPV Awareness Day.

The FDA granted priority review to pafolacianine sodium injection as an intraoperative adjunct to help identify ovarian cancer during surgery, according to the agent’s manufacturer.

Any aspirin use and aspirin use at least three times per week appeared associated with improvements in survival outcomes among older adults with bladder and breast cancers, according to study results published in JAMA Network Open.

The FDA granted fast track designation to GEN-1 for treatment of advanced ovarian cancer, according to the agent’s manufacturer.

Poly(ADP-ribose) polymerase, or PARP, inhibitors appeared associated with increased risk for secondary myelodysplastic syndrome and acute myeloid leukemia compared with placebo among patients with cancer, according to study results.

James K. Aikins Jr., MD, FACOG, FACS, has been appointed chief of gynecologic oncology at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital.

The FDA granted fast track designation to TH1902 for treatment of certain patients with sortilin-expressing cancers, according to the agent’s manufacturer.

A coalition of 76 cancer organizations today released an open letter urging Americans to make cancer care a priority amid the COVID-19 pandemic.

Kenneth H. Kim, MD, has been appointed director of Cedars-Sinai Cancer’s division of gynecologic oncology.